Investors File Securities Class Action Against PROCEPT BioRobotics

The complaint alleges that PROCEPT BioRobotics artificially inflated its financial performance through aggressive discounting tactics. These measures reportedly pulled future sales into current periods, resulting in a significant inventory glut that was not disclosed to the public. By allegedly issuing false and misleading statements throughout the class period, the company obscured its true financial health from the market.

Shareholders who incurred losses during this timeframe are invited to contact the DJS Law Group to discuss their eligibility for lead plaintiff status. While the deadline for action is September 22, 2026, the firm emphasizes that individuals do not need to be appointed as lead plaintiffs to participate in a potential recovery. David J. Schwartz, who leads the firm's efforts, specializes in corporate governance litigation and securities class actions.